Skip to main content
Clinical Trials/NCT01410773
NCT01410773
Completed
Not Applicable

Ninja 2 User Performance Evaluation

Ascensia Diabetes Care1 site in 1 country110 target enrollmentJuly 2011
ConditionsDiabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
Ascensia Diabetes Care
Enrollment
110
Locations
1
Primary Endpoint
Number of Self-Test Fingerstick Blood Glucose (BG) Results Within +/-15mg/dL(<75 mg/dL) or Within +/- 20% (>=75 mg/dL) of Laboratory Glucose Method
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to demonstrate that untrained subjects with diabetes can use an investigational Blood Glucose Monitoring System (BGMS) with capillary blood obtained from fingerstick and from Alternative Site (AST) Palm .

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
August 2011
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Ascensia Diabetes Care
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Males and females, 18 years of age and above
  • Diagnosed as having type 1 or type 2 diabetes
  • Currently self-testing blood glucose at home
  • Able to speak, read, and understand English
  • Willing to complete all study procedures

Exclusion Criteria

  • Blood Borne infections like hepatitis or HIV or infections such as tuberculosis
  • Hemophilia or any other bleeding disorder
  • Employee of competitive medical device company,immediate family member of such, or living within the household of such
  • Pregnancy

Outcomes

Primary Outcomes

Number of Self-Test Fingerstick Blood Glucose (BG) Results Within +/-15mg/dL(<75 mg/dL) or Within +/- 20% (>=75 mg/dL) of Laboratory Glucose Method

Time Frame: 1 hour

Untrained subjects with diabetes self-test fingerstick blood using an investigational Blood Glucose Meter (BGM). BGM results are compared with capillary plasma BG results obtained with a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG meter results are used to calculate the number of BG results within +/- 15mg/dL (for reference BG results \<75mg/dL) or within +/- 20%(for reference BG results \>=75mg/dL) of the reference method results (YSI capillary plasma).

Secondary Outcomes

  • Number of Alternative Site (AST) Palm Blood Glucose (BG) Results Within +/- 15mg/dL (<75mg/dL) or Within +/- 20% (>=75mg/dL) of Laboratory Glucose Method(1 hour)

Study Sites (1)

Loading locations...

Similar Trials